影响恶性青光眼预后及恢复时间的因素
该回顾性病例系列纳入单中心64眼(55例)恶性青光眼,分析影响治疗成功与恢复时间的因素。87.5%的眼需手术干预;30天内行玻璃体切除术者解剖、视力、眼压恢复更快;口服碳酸酐酶抑制剂或Nd:YAG激光玻璃体切开术者眼压降幅更大;眼压与视力最大改善时间可能长于解剖恢复时间。
要点
- 87.5%(56/64眼)恶性青光眼需手术干预。
- 30天内行玻璃体切除术者解剖、最佳视力、眼压恢复更快(P<.05)。
- 口服碳酸酐酶抑制剂或Nd:YAG激光玻璃体切开术者眼压降幅更大。
核心结论
- 更早行玻璃体切除术可能缩短恶性青光眼的恢复时间。
- Nd:YAG激光玻璃体切开术和口服碳酸酐酶抑制剂可能带来更大的眼压降幅。
- 眼压和最佳视力的最大改善时间可能长于解剖恢复时间。
- 小梁切除术可能延长恶性青光眼的恢复时间,而口服碳酸酐酶抑制剂可能缩短解剖恢复时间,前房形成可能加快眼压恢复。
研究设计与样本
- 回顾性病例系列,单中心,纳入64眼(55例)恶性青光眼,通过病历回顾分析解剖、眼压和最佳视力等主要结局指标。
主要发现
- 87.5%(56/64眼)恶性青光眼需手术干预。
- 有<3次切口手术史、<3种降眼压滴眼液或眼压≤30 mm Hg的眼行玻璃体切除术更可能成功(P<.05)。
- 30天内行玻璃体切除术者解剖、最佳视力和眼压恢复更早(P<.05)。
- 口服碳酸酐酶抑制剂(P=.016)或Nd:YAG激光玻璃体切开术(P=.007)者眼压降幅更大,无恶性青光眼病史者眼压降幅也更大(P=.007)。
- 眼压和最佳视力的最大改善时间显著长于解剖恢复时间(P<.001);口服碳酸酐酶抑制剂加快解剖恢复(P=.01);男性和非裔美国人最佳视力改善更快(P<.05);门诊行前房形成者眼压最大降幅出现更早(P<.002);恶性青光眼前行小梁切除术者解剖、最佳视力和眼压恢复延长(P<.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To identify factors associated with the successful treatment of malignant glaucoma (MG). DESIGN: Retrospective case series. METHODS: Setting: single institution; study population: 64 eyes (55 subjects) with MG; observation procedure(s): chart review; main outcome measures: anatomy, intraocular pressure (IOP), best visual acuity (BVA). RESULTS: 87.5% (n=56/64) of eyes with MG required surgical intervention. Vitrectomy was more likely to be successful in eyes with a history of <3 incisional surgeries, <3 glaucoma drops, or IOP ≤30 mm Hg (P < .05). If vitrectomy was performed within 30 days, recovery of anatomy, BVA, and IOP occurred sooner (P < .05). IOP reduction was greater in subjects treated with oral carbonic anhydrase inhibitors (P = .016) or Nd:YAG laser hyaloidotomy (P = .007), and without a history of MG (P = .007). Time to maximal improvement was significantly longer for IOP and BVA than anatomy (P < .001). Treatment of MG with an oral carbonic anhydrase inhibitor hastened anatomic recovery (P = .01). Time to improvement in BVA was significantly faster in men and African Americans (P < .05). Time to maximal reduction in IOP occurred sooner in eyes that underwent anterior chamber reformation in clinic (P < .002). Trabeculectomy surgery prior to MG was associated with prolonged recovery of anatomy, BVA, and IOP (P < .05). CONCLUSIONS: Earlier vitrectomy may shorten recovery times for MG. Nd:YAG laser hyaloidotomy and oral carbonic anhydrase inhibitors may lead to greater IOP reduction. The time to maximal improvement in IOP and BVA may be longer than the time to anatomic resolution. Although trabeculectomy may impede time to recovery from MG, oral carbonic anhydrase inhibitors may shorten the time to anatomic recovery and anterior chamber reformation may hasten IOP recovery.
引用
- Thompson AC, Vu DM, Postel EA, et al. Factors Impacting Outcomes and the Time to Recovery From Malignant Glaucoma. Am J Ophthalmol. 2019. PMID: 31377283. doi:10.1016/j.ajo.2019.07.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。